2/24
08:04 am
gbio
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference [Yahoo! Finance]
Medium
Report
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference [Yahoo! Finance]
2/24
06:59 am
gbio
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
Medium
Report
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
2/6
05:00 am
gbio
Tubulis Strengthens Executive Leadership with Appointment of Matthew Norkunas as Chief Financial Officer and President of Tubulis Inc.
Medium
Report
Tubulis Strengthens Executive Leadership with Appointment of Matthew Norkunas as Chief Financial Officer and President of Tubulis Inc.
1/8
08:00 am
gbio
Generation Bio Co. (NASDAQ: GBIO) had its price target lowered by analysts at Needham & Company LLC from $10.00 to $8.00. They now have a "buy" rating on the stock.
High
Report
Generation Bio Co. (NASDAQ: GBIO) had its price target lowered by analysts at Needham & Company LLC from $10.00 to $8.00. They now have a "buy" rating on the stock.
1/6
05:07 pm
gbio
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases [Yahoo! Finance]
High
Report
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases [Yahoo! Finance]
1/6
04:30 pm
gbio
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
Medium
Report
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases